Speech-Language Pathologists in Ermine, KY Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Mr. Jeffrey Len Holbrook, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 726 Combs Br, Ermine, KY 41815 Phone: 606-632-2151 |
News Archive
Autism Speaks releases 'Visual Supports' tool kit for parents, providers
Autism Speaks, North America's largest autism science and advocacy organization today released the Visual Supports and Autism Spectrum Disorder tool kit providing valuable guidance to parents, families and providers about how to utilize pictures, photographs and other visual supports to improve communication for children, adolescents and adults who struggle with understanding or using language.
FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the FDA has granted Breakthrough Therapy designation to volasertib, an investigational inhibitor of polo-like kinase, being evaluated for the treatment of patients aged 65 or older with previously untreated acute myeloid leukemia, ineligible for intensive remission induction therapy.
Pediatricians urge efforts to offset COVID-19 impacts on children from low-income households
The COVID-19 pandemic has magnified the social, educational and health care disparities already plaguing the nearly 40 million Americans the U.S. Census Bureau estimates are living in poverty.
Chronic consumption of western diet leads to overeating and obesity, new research shows
More than two in three adults in the United States are considered overweight or obese, with substantial biomedical and clinical evidence suggesting that chronic overconsumption of a "western diet" - foods consisting high levels of sugars and fats - is a major cause of this epidemic.
FDA intends to grant Priority Review designation for ThromboGenics' ocriplasmin
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the FDA intended to grant its recently-submitted ocriplasmin BLA (Biological License Application) for Priority Review.
› Verified 5 days ago